Announcement
18 Nov 2021
On 18 November 2021, the EIB provided financing worth EUR 350 million (USD 399 million) to Belgian biopharmaceutical company UCB SA in order to support its R&D and plant construction activities.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
18 Nov 2021
Revocation date:
No revocation date
Updated: 18 Nov 2021
State loan
In force
On 18 November 2021, the European Investment Bank (EIB) and Ucb Sa signed a loan agreement worth EUR 350 million (approx. USD 399 million). The total cost of the project is estimated at EUR 975 millio...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.